3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries
3D printing technology has emerged as a key driver behind an ongoing paradigm shift in the production process of various industrial domains. The integration of 3D printing into tissue engineering, by utilizing life cells which are encapsulated in specific natural or synthetic biomaterials (e.g., hyd...
Saved in:
Published in | Frontiers in medical technology Vol. 2; p. 607648 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
28.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 3D printing technology has emerged as a key driver behind an ongoing paradigm shift in the production process of various industrial domains. The integration of 3D printing into tissue engineering, by utilizing life cells which are encapsulated in specific natural or synthetic biomaterials (e.g., hydrogels) as bioinks, is paving the way toward devising many innovating solutions for key biomedical and healthcare challenges and heralds' new frontiers in medicine, pharmaceutical, and food industries. Here, we present a synthesis of the available 3D bioprinting technology from what is found and what has been achieved in various applications and discussed the capabilities and limitations encountered in this technology. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Sasan Jalili-Firoozinezhad, Koch Institute for Integrative Cancer Research at MIT, United States; Elena Pirogova, RMIT University, Australia This article was submitted to Pharmaceutical Innovation, a section of the journal Frontiers in Medical Technology Edited by: Khashayar Khoshmanesh, RMIT University, Australia |
ISSN: | 2673-3129 2673-3129 |
DOI: | 10.3389/fmedt.2020.607648 |